Back to Top
Labetuzumab Govitecan Biosimilar - Research Grade
Add recommended extras
Labetuzumab Govitecan Biosimilar - Research Grade
| Species Reactivity | Human |
|---|---|
| Target | CEACAM5 / CEA / CD66e |
| Concentration | 1mg/ml |
| Isotype | IgG1 |
| Host | CHO Cells |
| Shipping Conditions | Room Temp |
| background | Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity. |
| Other names | SN38 |
| Formulation | 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Purity | >90% by SDS-PAGE |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Applications | Functional Assays |
| Application Notes | Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex. |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Delivery Time | 1 week |
Write Your Own Review
Who Viewed This Also Viewed
Anti-Mouse Ly-6C (7B10) In Vivo Antibody - Low Endotoxin
$400.00 - $2,945.00
Anti-CD45R (RA3-6B2) In Vivo Antibody - Low Endotoxin
$400.00 - $3,780.00
Anti-ICAM-1 (15.2) In Vivo Antibody - Low Endotoxin
$400.00 - $3,780.00
Atezolizumab Biosimilar - Research Grade
$315.00 - $19,890.00
